Skip to main content

Table 3 Information of sample collection and prevalence of k13 mutation and pm2 with multi-copies in all the samples

From: No evidence of amplified Plasmodium falciparum plasmepsin II gene copy number in an area with artemisinin-resistant malaria along the China–Myanmar border

Sample collection Year Site k13 pm2
No. of tested No. of mutant % of mutant No. of tested No. of k13 wild-type No. of k13 mutant Single copy Multi-copies (> 1.6) % Of multi-copies
TES 2010 Yingjiang 26 16 61.5% 20 10 10 20 0 0.0%
2012 Tengchong 12 10 83.3% 10 1 9 10 0 0.0%
2012 Yingjiang 25 9 36.0% 20 16 4 20 0 0.0%
2013 Yingjiang 20 11 55.0% 19 9 10 19 0 0.0%
2013 Ruili 6 0 0.0% 6 6 0 6 0 0.0%
2014 Menglian 10 0 0.0% 10 10 0 10 0 0.0%
   Sub total 99 46 46.5% 85 52 33 85 0 0.0%
Passive detection 2011 Menglian County hospital 8 0 0.0%  
2011 Tengchong (Wuhe hospital) 125 49 39.0% 105 68 37 105 0 0.0%
2012 Yingjiang (Nabang Hospital) 4 2 50.0% 3 2 1 3 0 0.0%
2013 Tengchong County hospital 6 4 66. 7% 6 2 4 6 0 0.0%
2013 Yingjiang (Nabang Hospital) 12 11 91.7% 12 1 11 11 1a 9.1%
2014 Yingjiang (Nabang Hospital) 14 6 42.9% 13 8 5 13 0 0.0%
   Sub total 169 72 42.6% 139 81 58 138 11 9.1%
Total    268 118 44.0% 224 133 91 223 1 0.4%
  1. aThe only one sample with multi-copies of pm2 was carrying k13 mutant